Injection blow molding is the process that produces HDPE pharmaceutical containers, PP cosmetic jars, and ABS packaging with the most precise neck finish in blow molding — because the neck is injection moulded, not blown. This guide explains how the 3-station IBM process works, which materials it processes, where it outperforms extrusion blow molding and ISBM, and how Korean packaging factories select the right IBM machine for their production requirements.
Korea Ever-Power Engineering Desk · Ansan-si · July 2026
Injection Blow Molding — Key Process Reference
3 Stations
Injection → Blow → Stripping — concurrent operation every cycle
Zero Flash
No trimming, no parting-line seam — 100% material to finished bottle
1–2,000 ml
Bottle volume range — 10 ml eye drops to 2 L household containers
Up to 30
Max cavities at 10 ml — ZQ135 flagship — ~27,000 bottles per hour
Injection blow molding is a one-step plastic bottle manufacturing process that combines injection molding and blow molding in a single machine cycle. A preform — a thick-walled test-tube-shaped piece of resin — is first injection molded around a core rod at Station 1, then transferred on the rod to Station 2 where blow air inflates it against a blow mould cavity to form the finished bottle, then transferred to Station 3 where it is stripped from the rod and deposited onto the output conveyor. All three stations operate simultaneously on every cycle, making injection blow molding one of the most productive single-step packaging processes available to Korean container manufacturers.
The defining technical characteristic of injection blow molding is that the bottle neck is injection moulded — not blown. Because the core rod passes through the neck area during both injection and blow, the neck geometry is formed by the injection mould at Station 1 and is never deformed by blow pressure. This produces injection-moulded neck precision: thread OD tolerance of ±0.05 mm or better, consistent across every cavity in the mould, on every cycle. For Korean pharmaceutical packaging requiring CRC (child-resistant closure) engagement at ±0.06 mm neck OD tolerance, or Korean household chemical closures requiring consistent thread engagement across millions of units per shift, injection-moulded neck precision is the technical capability that positions injection blow molding as the preferred process over extrusion blow molding at these volume and tolerance requirements.
Injection blow molding was developed commercially in the 1950s as a response to the limitations of extrusion blow molding — specifically the flash that EBM generates at the parting line, the dimensional variation that EBM produces at the neck, and the trim operation that EBM requires after every cycle. IBM eliminates all three: zero flash, precision neck, no post-production trimming. These advantages drove IBM’s adoption in Korean pharmaceutical container manufacturing in the 1980s and 1990s, and the same advantages continue to define IBM’s position in Korean packaging today, now at cavity counts up to 30 per machine for the largest Korean pharmaceutical production lines.
At Station 1, the injection mould closes around the core rods — precision steel mandrels that define the interior geometry of the preform and, critically, the interior surface of the bottle neck. Molten resin is injected through the hot runner system to fill all cavities simultaneously. The injection mould forms the complete neck geometry (thread profile, thread OD, bore diameter, sealing surface) with the dimensional accuracy of injection tooling — tolerances that no other blow molding process can match at production speed. The injection clamping force at Station 1 holds the mould closed against injection pressure; on Korea Ever-Power’s ZQ series, this ranges from 400 KN on the ZQ40 to 1,350 KN on the ZQ135 — sized to support cavity counts from 9 to 30 at 10 ml format without flash at the neck parting line.
After the injection phase, the blow mould opens and the rotary turret — which carries all core rods simultaneously — lifts, rotates 120 degrees, and lowers to position each rod at the next station. On Korea Ever-Power’s ZQ80, ZQ110 and ZQ135 machines, a high-precision angle divider coordinates the mould opening motion with the turret lift, allowing these two mechanical events to overlap rather than executing fully sequentially. This overlap reduces the effective time lost between phases and ensures each rod registers to the correct station position with the same angular precision on every cycle — producing consistent cavity-to-cavity weight and dimensional performance that is directly measurable in production quality data.
At Station 2, the blow mould closes around the preform on the core rod. Compressed air (typically 0.7–1.2 MPa) enters through the core rod and inflates the preform against the blow mould cavity walls. Because the preform carries residual heat from the injection phase, and because the core rod holds the neck in its final geometry throughout, the blow phase produces the finished bottle body while the neck remains unchanged from its injection-moulded form. Blow clamping force ranges from 80 KN on the ZQ40 to approximately 180 KN on the ZQ135, matching the blow mould projected area at each cavity count.
At Station 3, finished bottles are stripped from the core rods and deposited onto the output conveyor. The stripping station applies a controlled force through the stripping mechanism to release the bottle from the rod without surface marking or neck deformation. At 30-cavity output on the ZQ135, 30 finished bottles are deposited per cycle — at the 4-second cycle time that is standard across the ZQ series, this is approximately 7.5 bottles per second to the output conveyor, requiring conveyor speed and accumulation capacity planning that Korea Ever-Power’s installation teams address during production cell layout.
Injection blow molding processes a wider range of thermoplastics than injection stretch blow molding (ISBM), because IBM does not require the molecular orientation that ISBM achieves in PET. IBM is compatible with any thermoplastic that can be injection moulded at the preform stage and retains sufficient heat and flexibility for blow inflation at Station 2.
| Material | Barrel Temp (°C) | Primary IBM Applications | Key Advantage |
|---|---|---|---|
| HDPE | 170–220 | Pharmaceutical bottles, eye drops, oral liquid, household chemical | Chemical resistance, FDA/KFDA compliance, low extractables |
| PP | 200–250 | CRC medicine bottles, hot-fill containers, condiment jars | Heat resistance, chemical resistance, autoclavable grades |
| ABS | 220–250 | Cosmetic jars, cream containers, wide-mouth packaging | Rigid, high-impact, excellent surface finish for decoration |
| PS | 180–240 | Dairy bottles, probiotic containers, ampoules, medical | Transparency, stiffness, food contact compliance |
| LDPE | 160–200 | Squeeze bottles, dropper bottles, ointment tubes | Flexibility, squeeze dispensing, soft touch |
| EVA | 155–180 | Specialty soft containers, flexible pharmaceutical packaging | Rubber-like flexibility, excellent low-temperature performance |
| PCTG | 240–265 | Premium cosmetic containers, clarity packaging, spirits bottles | Glass-like clarity, chemical resistance, FDA food contact |
Material versatility is one of injection blow molding’s commercial advantages over ISBM: the same IBM machine platform processes HDPE, PP, ABS and PS by adjusting barrel zone temperatures, screw speed and back pressure, without mechanical modification. A Korean pharmaceutical factory running HDPE eye drop bottles on a Monday and PP CRC medicine bottles on a Thursday uses the same IBM machine, the same mould change procedure, and the same operator training for both materials — a production flexibility that ISBM, which processes primarily PET, cannot offer across this material range.
Extrusion blow molding (EBM) is the most widely used blow molding process globally — large-format HDPE containers (jerricans, industrial drums, automotive tanks) and most consumer-size shampoo bottles produced before the mid-2000s used EBM. IBM occupies a different and more precise segment of the container market, and the two processes are not competitive in their core applications. Understanding where IBM is clearly superior to EBM — and where EBM retains its advantages — prevents Korean factories from choosing the wrong process for their specific container requirements.
| Comparison Criterion | Injection Blow Molding (IBM) | Extrusion Blow Molding (EBM) |
|---|---|---|
| Neck finish precision | Injection-moulded ±0.05 mm OD | Blown ±0.15–0.25 mm OD |
| Flash / trim generation | Zero flash — no trimming | Flash generated at base and neck — trim station required |
| Material utilisation | 100% — no scrap | 85–93% — flash is scrap or regrind |
| Wall thickness control | Excellent — preform defines wall distribution | Moderate — parison programming required for uniformity |
| Max bottle volume | Up to 2,000 ml (typical) | Up to 1,000 litres and above |
| Handle integration | Not possible in standard IBM | Yes — integral handles in EBM mould |
| Production output at 10 ml | Up to 27,000/hour (30 cavities) | Lower — typically 1–6 cavities for 10 ml format |
| Korean pharmaceutical GMP compliance | Excellent — injection neck standard | Requires additional neck validation |
The IBM vs EBM decision for Korean factories is straightforward when the container requires pharmaceutical-grade neck precision (IBM) or requires an integral handle or exceeds 2,000 ml (EBM). The challenging decision is in the middle range — small-to-medium HDPE household chemical containers where both processes are technically capable. In this range, IBM’s zero-flash advantage (no trim station, no scrap, lower operating cost) often justifies the higher IBM machine investment versus EBM, particularly for Korean factories producing at the 5–8 cavity 500 ml volumes where IBM output exceeds EBM output and IBM’s net material cost per bottle is lower when flash regrind costs are included.
IBM is the dominant process for Korean pharmaceutical HDPE and PP containers at small formats (1–100 ml). Eye drop bottles (10 ml HDPE), oral liquid vials (30 ml PP), syrup bottles (100 ml HDPE), CRC medicine bottles (100 ml PP) and unit-dose ampoules are all produced by injection blow molding — the injection-moulded neck produces the closure engagement precision that Korean KFDA GMP qualification requires. IBM’s zero-flash production eliminates the contamination risk from flash particles that trim-based EBM production introduces in cleanroom pharmaceutical environments.
Korean shampoo bottles, conditioner containers, body wash packaging and liquid detergent containers are produced by injection blow molding at 250–1,000 ml. IBM’s zero-flash production eliminates the trim station that EBM requires and reduces net material cost per bottle when regrind management is included. Korean food-grade injection blow molded containers include wide-mouth jars for honey, condiment and cooking oil at 250–500 ml, where IBM’s injection-moulded wide-mouth neck produces consistent closure seal across all cavities simultaneously. Wide-mouth jar production is a specific IBM native capability that ISBM machines cannot match at the same cavity counts.
Beyond pharmaceutical and household chemical applications, injection blow molding serves Korean cosmetic packaging (ABS cream jars, PCTG premium lotion bottles, PS ampoule-style serum vials), Korean food packaging (PP hot-fill containers, HDPE cooking oil bottles, food-grade wide-mouth jars), and Korean industrial containers (HDPE reagent bottles, PP chemical storage containers). The common thread across all IBM applications is the injection-moulded neck — the design requirement that pushes Korean packaging specifiers toward IBM regardless of the product category. When the closure requires consistent thread OD across all cavities and across all production shifts — whether the closure is a pharmaceutical CRC cap, a household chemical pump dispenser, or a wide-mouth food jar lid — injection blow molding is the process that reliably delivers that consistency at volume.
Injection blow molding (IBM) and injection stretch blow molding (ISBM) share the same defining characteristic — an injection-moulded neck — but they serve different materials and produce different bottle physics. Understanding the IBM vs ISBM distinction prevents the costly mistake of investing in the wrong platform. Korea Ever-Power manufactures both: the ZQ series IBM machines and the HGY series ISBM machines, available in the 4-Station ISBM Machine range.
| Factor | IBM (ZQ Series) | ISBM (HGY Series) |
|---|---|---|
| Primary materials | HDPE, PP, ABS, PS, LDPE, EVA, PCTG | PET, PETG, Tritan, PC, PP, PCTG |
| Bottle wall structure | Amorphous — no axial stretching | Biaxially oriented — glass-like PET clarity |
| HDPE pharmaceutical bottle | Native application | Not standard |
| Crystal-clear PET cosmetic serum | Not standard | Native application |
| Wide-mouth jar | Excellent — IBM native | Achievable with 4-station conditioning |
| Zero flash | Yes | Yes |
| Max cavities at 10 ml | Up to 30 (ZQ135) | Up to 12 (HGY series) |
The IBM vs ISBM decision resolves on material. If the Korean factory produces HDPE and PP containers — pharmaceutical, household chemical, food-grade — IBM is the correct platform. If the factory produces crystal-clear PET or PETG cosmetic bottles, premium serum ampoules or CSD-resistant PET beverage containers — ISBM is the correct platform. Korean factories producing both product lines run both platforms in parallel, each serving its native material. Korea Ever-Power can advise on the correct combination during pre-purchase technical discussion.
Korea Ever-Power’s injection blow molding machine range — the ZQ series — spans five models from the compact ZQ40 to the flagship ZQ135, covering every Korean IBM production scale from startup contract packaging to mega-scale pharmaceutical manufacturing. Each model is defined by its injection clamping force and maximum cavity count at 10 ml format. The ZQ80, ZQ110 and ZQ135 additionally include two premium features as standard: a high-precision angle divider for improved cycle repeatability, and a dual hydraulic system for 20–30% energy saving versus single-circuit competitors.
| Model | Clamping Force | Max Cavities @10ml | Total Power | Primary Korean Application |
|---|---|---|---|---|
| EP-ZQ40 | 400 KN | 9 | 20 KW | Small pharmaceutical startup, Korean CMO trial production, specialty formats |
| EP-ZQ60 | 600 KN | 14 | 37 KW | Korean mid-scale pharmaceutical, cosmetic jars, household chemical |
| EP-ZQ80 | 800 KN | 20 | 55 KW | Korean large pharmaceutical, Korean national brand household chemical |
| EP-ZQ110 | 1,100 KN | 24 | 80 KW | Korean large-scale pharmaceutical contract packaging, major Korean FMCG |
| EP-ZQ135 | 1,350 KN | 30 | 95 KW | Korean mega-scale pharmaceutical, national brand household chemical at highest volume |
The EP-ZQ60 is the most widely adopted ZQ model for Korean mid-scale pharmaceutical and cosmetic IBM production — the 14-cavity 10 ml and 3-cavity 500 ml configurations cover the most common Korean pharmaceutical contract packaging formats and household chemical container volumes that Korean national brand OEM factories produce. Korean factories whose annual 10 ml container production is below 50 million units typically find the ZQ60 the economically correct starting investment; those above 50 million units evaluate the ZQ80 or ZQ110 based on their specific cavity count and format requirements.
Korean injection blow molding is driven by three converging market forces that are each growing independently and reinforcing each other. First, Korean pharmaceutical volume growth: Korea’s pharmaceutical market — one of East Asia’s most regulated and quality-conscious — requires HDPE and PP pharmaceutical containers at precision standards that Korean KFDA qualification enforces. IBM is the only process that routinely passes Korean GMP container qualification for CRC pharmaceutical containers without additional neck finish processing. Korean pharmaceutical production growth, driven by Korean pharmaceutical export to Southeast Asian and US markets, directly increases Korean IBM machine demand.
Second, the Korean replacement of extrusion blow molding in household chemical packaging: Korean household chemical brands have been replacing EBM shampoo and cleaning product containers with IBM containers for the past decade. The IBM replacement is driven by IBM’s higher output per machine at small-to-medium cavity counts (8-cavity 500 ml IBM versus 4-cavity 500 ml EBM at the same cycle time), IBM’s zero-flash production economics (no trim station, no regrind), and Korean retailer QA requirements for dimensional consistency across packaging pallets that IBM’s injection-moulded neck precision satisfies more reliably than EBM.
Third, Korean government energy efficiency requirements: Korea’s industrial electricity pricing structure and the Korean government’s industrial energy efficiency programme have increased Korean packaging factory operators’ attention to machine-level energy consumption. Korea Ever-Power’s dual hydraulic IBM machines — the ZQ80, ZQ110 and ZQ135 — consume 20–30% less electricity per bottle produced than single-circuit competitor machines at equivalent output, a saving that Korean factory operators can document and include in Korean industrial energy efficiency reporting. For Korean factories participating in Korean government energy efficiency incentive programmes, this documented saving directly affects qualifying score and subsidy calculation. The combination of zero-flash material efficiency and 20–30% energy saving on the dual hydraulic ZQ models represents a compelling economics case for Korean IBM investment at every scale from startup pharmaceutical contract packaging to national brand consumer goods manufacturing.
Q1 — What is injection blow molding most commonly used for in Korea?
Korean injection blow molding is most commonly used for three container categories. First, HDPE pharmaceutical containers: 10 ml ophthalmic (eye drop) bottles, 30 ml oral liquid vials, 100 ml CRC medicine bottles and 250 ml syrup containers — all produced by IBM at precision standards required by Korean KFDA GMP qualification for pharmaceutical packaging. IBM’s injection-moulded neck produces the ±0.05 mm neck OD tolerance that Korean pharmaceutical CRC closures require across all cavities, making IBM the default process for Korean pharmaceutical contract packaging operations. Second, PP household chemical containers: 250–1,000 ml HDPE and PP shampoo, conditioner, body wash and cleaning product bottles produced by IBM in 5–8 cavity configurations replacing extrusion blow moulding for its zero-flash, zero-trim economics and dimensional precision. Third, ABS and PCTG cosmetic jars: wide-mouth 50–250 ml ABS cosmetic jars for Korean K-Beauty cream, mask and treatment packaging — where IBM’s wide-mouth native capability and surface quality meet Korean cosmetic brand visual specification requirements. In combination, these three Korean application categories define IBM as the primary process for rigid plastic container production in Korean pharmaceutical, household chemical and cosmetic packaging. Korean food packaging (wide-mouth food jars, cooking oil bottles, condiment containers) is a growing fourth application category as Korean food brands replace glass with injection blow moulded PP and HDPE containers to reduce weight and breakage at Korean online retail distribution.
Q2 — How does injection blow molding produce zero flash?
Injection blow molding produces zero flash because the plastic never contacts a parting line in an unsupported form. In extrusion blow molding, the extruded parison is clamped at the top and bottom by the closing blow mould, and the excess material that extends beyond the mould cavity boundary is pinched off to form flash — this is unavoidable in EBM because the parison must be long enough to span the full mould height with material to spare at the pinch zone. In IBM, there is no extruded parison. The preform at Station 1 is precisely injection moulded to contain exactly the amount of material needed for the finished bottle — the injection mould fills every cavity completely, with no excess material extending beyond the cavity boundary. When the preform is transferred to the blow station and inflated, the polymer simply redistributes from the preform shape to the blown bottle shape, with no material at any point exceeding the mould cavity boundary. The result is a finished bottle with no flash, no trim line, no base seam and no neck seam — only the injection gate witness mark at the inside of the bottle base from the injection moulding step, which is typically submillimetre in size and invisible from the exterior. For Korean pharmaceutical production this matters specifically because flash particles are a contamination risk in cleanroom environments that Korean KFDA pharmaceutical GMP requirements prohibit. IBM’s zero-flash production makes it inherently cleanroom-compatible without the particle-control measures that Korean EBM trim operations require.
Q3 — What is the difference between injection blow molding and injection stretch blow molding?
Injection blow molding (IBM) and injection stretch blow molding (ISBM) both produce bottles with injection-moulded necks — that is the shared characteristic. The difference is what happens at the blow station. In IBM, the preform is inflated by air pressure into the blow mould without axial stretching — the preform wall expands radially but does not elongate axially beyond the core rod length. The polymer chains in the bottle wall remain largely amorphous (unoriented). In ISBM, a stretch rod extends into the preform at the blow station and stretches the preform axially (lengthens it) at the same time that blow air inflates it radially — this biaxial stretching orientates the polymer chains in two directions, creating a crystalline structure in the bottle wall. For PET, this biaxial orientation produces the crystal clarity that glass-like PET cosmetic and beverage bottles exhibit — unoriented PET is cloudy. It also produces higher barrier performance (lower gas and moisture permeation) and higher top-load strength per unit weight. ISBM is used for PET, PETG, Tritan and similar orientation-responsive materials because orientation is what creates their performance advantages. IBM is used for HDPE, PP, ABS, PS, LDPE and EVA because these materials do not require orientation to achieve their functional properties — HDPE pharmaceutical containers do not need crystal clarity or gas barrier, they need chemical resistance and a precision neck finish, both of which IBM delivers without orientation. The practical selection rule: if the bottle must be crystal-clear PET — use ISBM. If the bottle is HDPE or PP pharmaceutical or household chemical — use IBM.
Q4 — What is the typical cycle time for injection blow molding and how many bottles per hour can an IBM machine produce?
Injection blow molding cycle time in Korea Ever-Power’s ZQ series is 3.5–4 seconds dry cycle across all models — from the ZQ40 to the ZQ135. The dry cycle (the time from one set of core rods completing the cycle to the next set completing the equivalent position, with no material in the machine) is the baseline against which actual production cycle time is compared. Actual production cycle time adds the injection hold time, blow hold time and stripping time beyond the dry cycle — typically adding 0.5–1.5 seconds to the dry cycle depending on material, wall thickness and bottle geometry. For a 10 ml HDPE eye drop bottle on a Korea Ever-Power ZQ machine at 4-second dry cycle and 88% practical production efficiency: the ZQ40 at 9 cavities produces approximately 7,100 bottles per hour; the ZQ60 at 14 cavities produces approximately 11,100 bottles per hour; the ZQ80 at 20 cavities produces approximately 15,800 bottles per hour; the ZQ110 at 24 cavities produces approximately 19,000 bottles per hour; and the ZQ135 at 30 cavities produces approximately 23,800 bottles per hour. The Korean factory planning calculation uses cavities × (3,600 seconds ÷ cycle time) × practical efficiency to determine the bottles-per-hour basis for production capacity planning, shift staffing and annual capacity calculation. At the ZQ135 scale, approximately 23,800 bottles per hour at 14 operating hours per Korean two-shift day equals approximately 333,000 bottles per day — approximately 83 million 10 ml containers per year at 250 production days — the highest annual output of any hydraulic IBM machine in Korea Ever-Power’s range.
Q5 — What makes Korea Ever-Power’s ZQ series injection blow molding machines different from other IBM machines?
Korea Ever-Power’s ZQ series injection blow molding machines are differentiated from competitor IBM machines by three structural features that are included as standard rather than as optional upgrades. First, European-style clamping architecture: the ZQ series injection clamping force is 20–30% higher than the industry standard for the equivalent machine class — 400 KN on the ZQ40 where competitor machines at the same cavity count offer 280–320 KN. This clamping surplus provides a wider process window for Korean pharmaceutical CRC neck production, where the required per-cavity clamping force is within the ZQ series rated capacity rather than at its ceiling. Second, high-precision angle divider (ZQ80 and above): the device that coordinates the mould opening motion with the rotary turret’s lift and rotation, allowing these two mechanical events to overlap rather than execute sequentially. The angle divider improves effective throughput by reducing cycle dead time and improves indexing repeatability — measurable as tighter cavity-to-cavity weight standard deviation in production sampling. On competitor machines in this class, the angle divider is an upgrade option; on ZQ80, ZQ110 and ZQ135, it is standard equipment from the first production day. Third, dual hydraulic system (ZQ80 and above): two independent hydraulic circuits — one serving the injection-side functions, one serving the blow-side functions — allow each circuit to operate at its own optimal pressure and flow rate, with each pump reducing to near-idle load when its served function is in the low-demand phase. The measured result is 20–30% lower electricity consumption per 1,000 bottles versus single-circuit competitor machines at equivalent output. For Korean factories participating in Korean government industrial energy efficiency reporting, this documented energy advantage directly supports classification and subsidy eligibility.
Q6 — How do I decide which ZQ injection blow molding machine model is right for my Korean factory?
The ZQ model selection decision follows a three-step framework that Korea Ever-Power’s engineering team applies when advising Korean factory investment decisions. Step 1 — Define the primary production format: the smallest volume container the factory will produce at the highest annual quantity is the primary format that determines the required cavity count. For most Korean pharmaceutical factories, this is 10 ml or 30 ml HDPE containers. The required annual output at the primary format divided by the annual machine operating hours at standard Korean two-shift production (approximately 3,500 hours per year) equals the required bottles per hour. Match this figure to the ZQ model cavity count: 9 cavities (ZQ40) at 7,100/hour, 14 cavities (ZQ60) at 11,100/hour, 20 cavities (ZQ80) at 15,800/hour, 24 cavities (ZQ110) at 19,000/hour, 30 cavities (ZQ135) at 23,800/hour. Step 2 — Check the secondary format requirements: if the factory also produces large-format containers (250–1,000 ml) on the same machine, verify that the selected model provides adequate shot weight at the larger format. ZQ40 (9 cavities at 10 ml) runs 3 cavities at 250 ml; ZQ80 (20 cavities at 10 ml) runs 8 cavities at 250 ml. Ensure the selected model covers both formats at required output without changing the machine model between format changeovers. Step 3 — Assess five-year growth: if Korean pharmaceutical export contracts or Korean retail channel growth is forecast to push the primary format’s annual requirement above the selected model’s output ceiling within three to five years, consider investing in the next model up at initial purchase — the machine will run at partial capacity initially but eliminates a machine replacement cycle within the planning horizon. Korea Ever-Power’s application engineers provide a formatted capacity analysis worksheet that applies this three-step framework to specific Korean factory production programmes, available through the Korea Ever-Power technical enquiry process.
IBM Machine Enquiry
Korea Ever-Power’s engineering team provides IBM machine selection consultation, cavity count analysis and production cell layout planning for Korean pharmaceutical, household chemical and cosmetic packaging factories at all production scales.
Related Resources
IBM PHARMACEUTICAL TABLET BOTTLE · PP HDPE OTC RX · CRC INDUCTION SEAL · KOREA…
IBM HAIR CARE BOTTLE · PP PCTG SHAMPOO CONDITIONER · K-BEAUTY OEM · KOREA EVER-POWER…
IBM CYCLE TIME · ZQ MACHINE PARAMETERS · COOLING DWELL · PP HDPE PCTG ·…
IBM MOULD STEEL · H13 P20 S136 TOOLING · HARDNESS POLISHABILITY · SERVICE LIFE ·…
IBM NECK FINISH STANDARDS · GPI BPF PCO THREAD · CRC FITMENT · NECK OD…
IBM DISINFECTANT BOTTLE · PP HDPE ANTISEPTIC · HAND SANITISER · ETHANOL · KOREA EVER-POWER…